Placental transfer and maternal and fetal hemodynamic effects of ketanserin in the pregnant ewe

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 68, Issue 1-2, 1996, Pages 179-184

  Schneider, Tom J ^a   Struijk, Piet C ^a   Lotgering, Fred K ^a   Wallenburg, Henk C S ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Ketanserin; Pregnant ewe; Serotonin; Uterine blood flow

Indexed keywords

KETANSERIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CATTLE; CONTROLLED STUDY; DRUG EFFECT; FETUS; HEMODYNAMICS; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL; UTERUS BLOOD FLOW; VASOCONSTRICTION;

EID: 0030248335     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-2115(96)02478-5     Document Type: Article

References (20)

1. [1] Visser W, Wallenburg HCS. Central hemodynamic observations in untreated preeclamptic patients. Hypertension 1991; 17: 1072-1077.
2. [2] Wallenburg HCS, Rotmans P. Enhanced reactivity of the platelet thromboxane pathway in normotensive and hypertensive pregnancies with insufficient growth. Am J Obstet Gynecol 1982; 144: 523-528.
3. [3] Redman CWG. Platelets and the beginning of preeclampsia. N Engl J Med 1990; 323: 478-480.
4. [4] Weyrich AS, Solis GA, Li KS, Tulenko TN, Santamore WP. Platelet amplification of vasospasm. Am J Physiol 1992; 263: 349-358.
5. [5] Weiner CP. The role of serotonin in the preeclampsia eclampsia-syndrome. Cardiovasc Drugs Ther 1990; 4: 37-43.
6. [6] van Zwieten PA, Blauw GJ, van Brummelen P. Serotonergic receptors and drugs in hypertension. Pharmacol Toxicol 1992; 70: S17-S22.
7. [7] Wenting GJ, Man in't Veld AJ, Woittiez AJJ, Boomsma F, Schalekamp MADH. Treatment of hypertension with ketanserin, a new selective 5-HT-2 receptor agonist. Br Med J 1982; 284: 537-539.
8. [8] De Clerck F, David JL, Janssen PAJ. Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R41486), a selective 5-HT-2-receptor antagonist. Agents Actions 1982; 12: 388-397.
9. [9] Weiner CP, Socol ML, Vaisrub N. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist. Am J Obstet Gynecol 1984; 149: 496-500.
10. [10] Montenegro R, Knuppel RA, Shah D, O'Brien WF. The effect of serotonergic blockade in postpartum preeclamptic patients. Am J Obstet Gynecol 1985; 153: 130-134.
11. [11] Hulme VA, Odendaal HJ. lntrapartum treatment of preeclamptic hypertension by ketanserin. Am J Obstet Gynecol 1986; 155: 260-263.
12. [12] Voto LS, Zin C, Neira J, Lapidus AM, Margulies M. Ketanserin versus α-methyldopa in the treatment of hypertension during pregnancy: a preliminary report. J Cardiovasc Pharmacol 1987; 10: S101-S103.
13. [13] Rossouw HJ, Howarth G, Odendaal HJ. Ketanserin and hydralazine in hypertension in pregnancy - a randomized double-blind trial. S Afr Med J 1995; 85: 525-528.
14. [14] Furuhashi N, Tsujiei M, Kimura H, Yajima A. Effects of ketanserin - a serotonin receptor antagonist - on placental blood flow, placental weight and fetal weight of spontaneously hypertensive rats and normal wistar kyoto rats. Gynecol Obstet Invest 1991; 32: 65-67.
15. [15] Okonkwo PO, Reimann IW, Woestenborghs R. High performance liquid chromatographic assay with fluorometric detection of ketanserin, a new antihypertensive agent and serotonin S-2 antagonist in human plasma, blood and urine. J Chromatogr 1983; 272: 411-416.
16. [16] Heykants J, van Peer A, Woestenborghs R, Gould S, Mills J. Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration. Eur J Clin Pharmacol 1986; 31: 343-350.
17. [17] Lang U, Prada J, Clark KE. Systemic and uterine vascular response to serotonin in third trimester pregnant ewes. Eur J Obstet Gynecol Reprod Biol 1993; 51: 131-138.
18. [18] Zhang L, Dyer DC. Characterization of 5-hydroxytryptamine receptors on isolated ovine uterine artery in late pregnancy. J Pharmacol Exp Ther 1990; 253: 1236-1244.
19. [19] Zhang L, Dyer DC, Hembrough FB, Isla M. Effect of R(-)2,5-dimethoxy-4-methylamphetamine on uterine and umbilical blood flow in conscious pregnant sheep. Eur J Pharmacol 1991; 199: 179-184.
20. [20] Nelson MA, Coghlan JP, Denton DA et al. Demonstration of α-adrenoreceptor antagonism by the 5-HT-2 antagonist ketanserin (R49945) in sheep. Clin Exp Pharmacol Physiol 1984; 11: 597-604.